» Articles » PMID: 16246840

Nitric Oxide Negatively Regulates Fas CD95-induced Apoptosis Through Inhibition of Ubiquitin-proteasome-mediated Degradation of FLICE Inhibitory Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Oct 26
PMID 16246840
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Stimulation of cell surface Fas (CD95) results in recruitment of cytoplasmic proteins and activation of caspase-8, which in turn activates downstream effector caspases leading to programmed cell death. Nitric oxide (NO) plays a key role in the regulation of apoptosis, but its role in Fas-induced cell death and the underlying mechanism are largely unknown. Here we show that stimulation of the Fas receptor by its ligand (FasL) results in rapid generation of NO and concomitant decrease in cellular FLICE inhibitory protein (FLIP) expression without significant effect on Fas and Fas-associated death domain (FADD) adapter protein levels. FLIP down-regulation as well as caspase-8 activation and apoptosis induced by FasL were all inhibited by the NO-liberating agent sodium nitroprusside and dipropylenetriamine NONOate, whereas the NO synthase inhibitor aminoguanidine and NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (PTIO) had opposite effects, indicating an anti-apoptotic role of NO in the Fas signaling process. FasL-induced down-regulation of FLIP is mediated by a ubiquitin-proteasome pathway that is negatively regulated by NO. S-nitrosylation of FLIP is an important mechanism rendering FLIP resistant to ubiquitination and proteasomal degradation by FasL. Deletion analysis shows that the caspase-like domain of FLIP is a key target for S-nitrosylation by NO, and mutations of its cysteine 254 and cysteine 259 residues completely inhibit S-nitrosylation, leading to increased ubiquitination and proteasomal degradation of FLIP. These findings indicate a novel pathway for NO regulation of FLIP that provides a key mechanism for apoptosis regulation and a potential new target for intervention in death receptor-associated diseases.

Citing Articles

The Crosstalk of Apoptotic and Non-Apoptotic Signaling in CD95 System.

Seyrek K, Espe J, Reiss E, Lavrik I Cells. 2024; 13(21.

PMID: 39513921 PMC: 11545656. DOI: 10.3390/cells13211814.


Apoptosis and eryptosis: similarities and differences.

Tkachenko A Apoptosis. 2023; 29(3-4):482-502.

PMID: 38036865 DOI: 10.1007/s10495-023-01915-4.


Restoring TRAILR2/DR5-Mediated Activation of Apoptosis upon Endoplasmic Reticulum Stress as a Therapeutic Strategy in Cancer.

Mora-Molina R, Lopez-Rivas A Int J Mol Sci. 2022; 23(16).

PMID: 36012252 PMC: 9409255. DOI: 10.3390/ijms23168987.


Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.

Nakamura T, Oh C, Zhang X, Lipton S Free Radic Biol Med. 2021; 172:562-577.

PMID: 34224817 PMC: 8579830. DOI: 10.1016/j.freeradbiomed.2021.07.002.


Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression.

Kim S, Seo S, Min K, Woo S, Nam J, Kubatka P Molecules. 2018; 23(7).

PMID: 30004456 PMC: 6099973. DOI: 10.3390/molecules23071614.